Global Ventricular Assist Devices Market

February 2019 | 84 pages | ID: G026C731007EN
IHR Insights

Abstracts

Global Ventricular Assist Devices Market 2019–2025

[84 pages report] This market research report includes a detailed segmentation of the global ventricular assist devices market – By Product (Left Ventricular Assist Devices [LVAD], Right Ventricular Assist Devices [RVAD], and Biventricular Assist Devices [BIVAD]), By Design (Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices), By Application (Bridge-to-Transplant [BTT] Therapy, Destination Therapy, Bridge-to-Recovery [BTR] Therapy, and Bridge-to-Candidacy [BTC] Therapy), and By Region (North America, Europe, Asia Pacific and Rest of the World)

Overview of the Global Ventricular Assist Devices Market Research

Infoholic’s market research report predicts that the global ventricular assist devices market will grow at a CAGR of 13.8% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of innovative products have increased the acceptance of heart assist devices in the market. The market is fueled by increase in the incidence of heart failure, lack of heart donors for transplantation, and increasing elderly population.

The market continues to grow and is one of the most widely used devices for the functioning of heart in cardiac failure and weakened heart patients. The market is getting revolutionized with the advancement in technology. Vendors are focusing towards new product launches, product approvals, and targeting towards end-user’s perspective. The market generates the revenue from the key players operating in this field and some of vendors are Medtronic plc, Reliant Heart Inc., Abbott Laboratories, Berlin Heart GmbH, Jarvik Heart, Inc., and ABIOMED, Inc.

According to Infoholic Research analysis, North America accounted for the largest share of the global ventricular assist devices market in 2018 and will retain high position during the forecast period. According to American Heart Association, an estimated 92.1 million population in the US have at least one type of CVD and by 2030 it is projected that 43.9% of the US adult population to have some form of CVD. Favorable reimbursement policies, availability of advanced technologies, and growing cardiovascular diseases will increase the adoption and demand of the devices in this region. The Asia Pacific is expected to grow during the forecast period, owing to factors such as high prevalence of cardiovascular diseases, increasing healthcare expenditure, and presence of huge population base.

By Product:

• Left Ventricular Assist Devices (LVAD)
• Right Ventricular Assist Devices (RVAD)
• Biventricular Assist Devices (BIVAD)

In 2018, the left ventricular assist devices segment occupied the largest share and is expected to grow at high CAGR during the forecast period. Increasing number of patients suffering from last-stage heart failure, advancement in technology such as effectiveness, high survival rate, and decreased risk of the devices makes the segment the most common among other VAD devices.

By Design:

• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices

In 2018, the implantable ventricular assist devices segment occupied the largest share and is expected to grow at high CAGR during the forecast period.

By Application:

• Bridge-to-Transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-Recovery (BTR) Therapy
• Bridge-to-Candidacy (BTC) Therapy

By application, the bridge-to-recovery (BTR) therapy generated the maximum revenue, thus accounting for more than 35% of the global ventricular assist devices market in 2018 and the segment is expected to grow at high CAGR during the forecast period. The destination therapy segment is expected to be the second highest growing segment during the forecast period.

By Regions:

• North America
• Europe
• APAC
• ROW

The market is dominated by North America, followed by Europe and Asia Pacific. US occupied the major share of the North American market due to the increasing disease prevalence and availability of advanced technologies.

Ventricular Assist Devices Market Research Competitive Analysis – The global ventricular assist devices market has massive growth opportunities in both developed and developing regions. The advancement and upgradation of devices will increase the competition among vendors. Many vendors are focusing on product approvals and developing innovative products to strengthen their product portfolio that intensifies the market competition. In October 2018, FDA approved HeartMate 3 left ventricular assist device developed by Abbott, as a destination therapy for patients with advanced heart failure. The approval device supported by the Momentum 3 trial showed a survival rate of 82.8% at two years with rates of suspected pump thrombosis at only 1.1%. Health Canada issued a Class IV License with conditions to HeartMate 3 left ventricular assist system developed by Thoratec Corporation in 2018. In 2018, Calon Cardio-Technology has launched a clinical trial of the UK's first artificial heart pump. In addition, other leading players are focusing in huge investments on research and development activities to develop new products to attain maximum share in the market.

Key vendors:

• Medtronic plc
• Abbott Laboratories
• ReliantHeart Inc.
• Berlin Heart GmbH
• Jarvik Heart, Inc.
• ABIOMED, Inc.
• BiVACOR
• Calon Cardio-Technology Ltd.
• LivaNova PLC
• Evaheart Medical USA, Inc. (Asahi Kasei Corp.)
• Fresenius Medical Care AG & Co. KGaA (XENIOS AG)
• Maquet GmbH (Getinge AB)

Key competitive facts

• The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.
• The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Benefits – The report provides complete details about the usage and adoption rate of ventricular assist devices. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

• Understanding the potential market opportunity with precise market size and forecast data
• Detailed market analysis focusing on the growth of ventricular assist devices industry
• Factors influencing the growth of ventricular assist devices market
• In-depth competitive analysis of dominant and pureplay vendors
• Prediction analysis of ventricular assist devices industry in both developed and developing regions
• Key insights related to major segments of the ventricular assist devices market
• Latest market trend analysis impacting the buying behavior of the consumers

Contents

1 INDUSTRY OUTLOOK

1.1 Industry Overview
  1.1.1 Geography
  1.1.2 Medical Technologies
  1.1.3 Industry Trends
1.2 Total Addressable Market

2 REPORT OUTLINE

2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 MARKET SNAPSHOT

3.1 Market Definition – Infoholic Research
3.2 Device Benefits
3.3 Segmented Addressable Market (SAM)
3.4 Trends in the Ventricular Assist Devices Market
3.5 Related Markets
  3.5.1 Stents
  3.5.2 Interventional Cardiology
  3.5.3 Angioplasty

4 MARKET OUTLOOK

4.1 Regulatory Status
4.2 Reimbursement
4.3 Market Segmentation
4.4 PEST Analysis
4.5 Porter 5(Five) Forces

5 MARKET CHARACTERISTICS

5.1 DRO – Global Ventricular Assist Devices Market Dynamics
  5.1.1 Drivers
    5.1.1.1 Upsurge in the incidence of cardiovascular disease (CVD)
    5.1.1.2 Growing geriatric population
    5.1.1.3 Dearth of heart donors across the globe
  5.1.2 Opportunities
    5.1.2.1 Increased approvals, fun ding, and pipeline products
    5.1.2.2 Upsurge in healthcare spending and demand for better treatment in emerging economies
  5.1.3 Restraints
    5.1.3.1 High cost of the devices
    5.1.3.2 Strict regulatory policies
5.2 DRO – Impact Analysis
5.3 Key Stakeholders

6 PRODUCT: MARKET SIZE AND ANALYSIS

6.1 Overview
6.2 Left Ventricular Assist Devices
6.3 Right Ventricular Assist Devices
6.4 Biventricular Assist Devices

7 DESIGN: MARKET SIZE AND ANALYSIS

7.1 Overview
7.2 Transcutaneous Ventricular Assist Devices
7.3 Implantable Ventricular Assist Devices

8 APPLICATIONS: MARKET SIZE AND ANALYSIS

8.1 Overview
8.2 Bridge-to-Transplant (BTT) Therapy
8.3 Destination Therapy
8.4 Bridge-to-Recovery (BTR) Therapy
8.5 Bridge-to-Candidacy (BTC) Therapy

9 REGIONS: MARKET SIZE AND ANALYSIS

9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World

10 COMPETITIVE LANDSCAPE

10.1 Overview

11 VENDOR PROFILES

11.1 Medtronic plc
  11.1.1 Overview
  11.1.2 Business Units
  11.1.3 Geographic Presence
  11.1.4 Business Focus
  11.1.5 SWOT Analysis
  11.1.6 Business Strategies
11.2 Abbott Laboratories
  11.2.1 Overview
  11.2.2 Business Units
  11.2.3 Geographic Presence
  11.2.4 Business Focus
  11.2.5 SWOT Analysis
  11.2.6 Business Strategies
11.3 Reliant Heart Inc.
  11.3.1 Overview
  11.3.2 Business Focus
  11.3.3 SWOT Analysis
  11.3.4 Business Strategies
11.4 Jarvik Heart, Inc.
  11.4.1 Overview
  11.4.2 Business Focus
  11.4.3 SWOT Analysis
  11.4.4 Business Strategies
11.5 Berlin Heart GmbH
  11.5.1 Overview
  11.5.2 Business Focus
  11.5.3 SWOT Analysis
  11.5.4 Business Strategies

12 COMPANIES TO WATCH FOR

12.1 BiVACOR
  12.1.1 Overview
12.2 ABIOMED, Inc.
  12.2.1 Overview
  12.2.2 ABIOMED, Inc.: Recent Developments
12.3 Calon Cardio-Technology Ltd.
  12.3.1 Overview
  12.3.2 Calon Cardio-Technology Ltd.: Recent Developments
12.4 Maquet GmbH (Getinge AB)
  12.4.1 Overview
  12.4.2 Maquet GmbH (Getinge AB): Recent Developments
12.5 LivaNova PLC
  12.5.1 Overview
  12.5.2 LivaNova PLC: Recent Developments
12.6 Evaheart Medical USA, Inc. (Asahi Kasei Corp.)
  12.6.1 Overview
  12.6.2 Evaheart Medical USA, Inc.: Recent Developments
12.7 Fresenius Medical Care AG & Co. KGaA (XENIOS AG)
  12.7.1 Overview
  12.7.2 Fresenius Medical Care AG & Co. KGaA (XENIOS AG): Recent Developments

13 ANNEXURE

13.1 Abbreviations

List Of Tables

LIST OF TABLES

TABLE 1 REGULATORY STATUS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET
TABLE 2 GLOBAL VENTRICULAR ASSIST DEVICES MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION)
TABLE 3 OTHER PROMINENT VENDORS OF VENTRICULAR ASSIST DEVICES MARKET
TABLE 4 MEDTRONIC PLC: OFFERINGS
TABLE 5 MEDTRONIC PLC: RECENT DEVELOPMENTS
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 8 RELIANTHEART INC.: OFFERINGS
TABLE 9 RELIANTHEART INC.: RECENT DEVELOPMENTS
TABLE 10 JARVIK HEART, INC.: PRODUCT OFFERINGS
TABLE 11 JARVIK HEART, INC.: RECENT DEVELOPMENTS
TABLE 12 BERLIN HEART GMBH: PRODUCT OFFERINGS
TABLE 13 BERLIN HEART GMBH: RECENT DEVELOPMENTS
TABLE 14 BIVACOR: SNAPSHOT
TABLE 15 ABIOMED, INC.: SNAPSHOT
TABLE 16 CALON CARDIO-TECHNOLOGY LTD.: SNAPSHOT
TABLE 17 MAQUET GMBH (GETINGE AB): SNAPSHOT
TABLE 18 LIVANOVA PLC.: SNAPSHOT
TABLE 19 EVAHEART MEDICAL USA, INC.: SNAPSHOT
TABLE 20 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): SNAPSHOT

List Of Figures

LIST OF FIGURES

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
CHART 2 RESEARCH METHODOLOGY OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET
CHART 3 GLOBAL VENTRICULAR ASSIST DEVICES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 4 SEGMENTATION OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET
CHART 5 PEST ANALYSIS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET
CHART 6 PORTER 5 FORCES ON GLOBAL VENTRICULAR ASSIST DEVICES MARKET
CHART 7 MARKET DYNAMICS – DRO ANALYSIS
CHART 8 DRO – IMPACT ANALYSIS OF GLOBAL VENTRICULAR ASSIST DEVICES MARKET
CHART 9 KEY STAKEHOLDERS OF THE GLOBAL VENTRICULAR ASSIST DEVICES MARKET
CHART 10 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2018 (%)
CHART 11 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY TECHNOLOGY SEGMENTATION, 2025 (%)
CHART 12 GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 13 GLOBAL RIGHT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 14 GLOBAL BIVENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY DESIGN SEGMENTATION, 2018 (%)
CHART 16 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY APPLICATION SEGMENTATION, 2018 (%)
CHART 17 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY APPLICATION SEGMENTATION, 2025 (%)
CHART 18 GLOBAL BRIDGE-TO-TRANSPLANT (BTT) THERAPY MARKET FORECAST, 2018–2025 ($MILLION)
CHART 19 GLOBAL DESTINATION THERAPY MARKET FORECAST, 2018–2025 ($MILLION)
CHART 20 GLOBAL BRIDGE-TO-RECOVERY (BTR) THERAPY MARKET FORECAST, 2018–2025 ($MILLION)
CHART 21 GLOBAL BRIDGE-TO-CANDIDACY (BTC) THERAPY MARKET FORECAST, 2018–2025 ($MILLION)
CHART 22 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%)
CHART 23 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%)
CHART 24 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 25 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 26 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION)
CHART 27 VENTRICULAR ASSIST DEVICES MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION)
CHART 28 MEDTRONIC PLC: OVERVIEW SNAPSHOT
CHART 29 MEDTRONIC PLC: BUSINESS UNITS
CHART 30 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
CHART 31 MEDTRONIC PLC: SWOT ANALYSIS
CHART 32 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
CHART 33 ABBOTT LABORATORIES: BUSINESS UNITS
CHART 34 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE
CHART 35 ABBOTT LABORATORIES: SWOT ANALYSIS
CHART 36 RELIANTHEART INC.: SWOT ANALYSIS
CHART 37 JARVIK HEART, INC.: SWOT ANALYSIS
CHART 38 BERLIN HEART GMBH: SWOT ANALYSIS